tada

At this stage I have no idea. Having just looked at bear's posts I feel much more positive about zen3694 and the underlying theory for it's development.

Back in 2013 in the spring when spinco (Zenith) was spun out I was extremely excited because I felt there was a high probability that ASSURE would succeed and thus lead to a potential buy out of RVX or at least rvx-208 in a CVR deal. Thus Don and team would be left with a "pot of gold" to build Zenith. We all know this did not happen.

RVX is currently in a very interesting situation pending some positive news on apabetalone re 3 pt MACE and a possible deal of some sort.

In hind site I give Don and team credit for spinning off the Zenith assets into a private, fully protected company. Then the creation of Zenith Capital and Zenith Epigenetics was another brilliant move. As San Fran says Zenith Epigenetics can be a star factory over many years for many indications (this applies to RVX as well).

I do not want to see Zenith bought in total. There is far too much upside. A licensing deal on zen3694 would be excellent.

Bear's posting gives me hope that zen3694 is on the right track...but we have not heard any news.

My bottom line is that as critical as I have been of Don he seems to steer a steady course and also the scince team seems very strong.

I sure would like to hear something from the trial.

GLTA

Toinv